Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Boulder Diagnostics

2009 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$7.9M LATEST DEAL AMOUNT
Description

Developer of immunology-based assays designed to treat rheumatology and infectious diseases. The company is primarily engaged in developing diagnostic reagents and tests for infectious diseases and other protein targets.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 6395 Gunpark Drive
  • Suite W
  • Boulder, CO 80301
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Boulder Diagnostics’s full profile, request a free trial.

Boulder Diagnostics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 31-Jul-2014 $7.9M 00.00 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Boulder Diagnostics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Reich Consulting Venture Capital Minority 000 0000 000000 0
Ventac Partners Venture Capital Minority 000 0000 000000 0

Boulder Diagnostics Executive Team (3)

Name Title Board
Seat
Contact
Info
Roy Mondesire Ph.D Scientific Consultant

2 Former Executives

You’re viewing 1 of 3 executives. Get the full list »